← Explorer/Network

Invasion of Human Skin Fibroblasts by the Lyme Disease Spirochete, Borrelia burgdorferi

Klempner MS, Noring R, Rogers RA1993The Journal of Infectious DiseasesJournal Article
10.1093/infdis/167.5.1074PubMed
DermatologicalMusculoskeletalNeurological
Lyme & Co-Infections

Abstract

The ability of Borrelia burgdorferi to attach to and invade human fibroblasts was investigated by scanning electron and confocal microscopy. By scanning electron microscopy, B. burgdorferi were tightly adherent to fibroblast monolayers after 24-48 h but were eliminated from the cell surface by treatment with ceftriaxone (1 microgram/mL) for 5 days. Despite the absence of visible spirochetes on the cell surface after antibiotic treatment, viable B. burgdorferi were isolated from lysates of the fibroblast monolayers. B. burgdorferi were observed in the perinuclear region within human fibroblasts by laser scanning confocal microscopy. Intracellular spirochetes specifically labeled with monoclonal anti-flagellin antibody were also identified by fluorescent laser scanning confocal microscopy. These observations suggest that B. burgdorferi can adhere to, penetrate, and invade human fibroblasts in organisms that remain viable.

Key Biomarkers

IgG antibodies to Borrelia burgdorferiIgM antibodies to Borrelia burgdorferiPCR detection of Borrelia burgdorferi genetic material

Symptom Clusters

Early acute Lyme diseaseErythema migrans (EM) rashMulti-stage Lyme borreliosis

Cited By (5)

  • Borrelia burgdorferiInduces TLR1 and TLR2 in Human Microglia and Peripheral Blood Monocytes but Differentially Regulates HLA-Class II ExpressionJournal of Neuropathology & Experimental Neurology · 2006
  • Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClinical Infectious Diseases · 2007
  • Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated CoinfectionsMicroorganisms · 2023
  • Ultrastructural demonstration of spirochetal antigens in synovial fluid and synovial membrane in chronic lyme disease: Possible factors contributing to persistence of organismsHuman Pathology · 1996
  • Lyme borreliosis: basic science and clinical aspectsThe Lancet · 1994

References (3)

  • Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosisInfection · 1989

Related Papers

  • Fibronectin binding protein BBK32 of the lyme disease spirochete promotes bacterial attachment to glycosaminoglycansInfection and Immunity · 2006 · 4 shared tags
  • Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu latoResearch in Microbiology · 1995 · 4 shared tags
  • Clinical Pathologic Correlations of Lyme DiseaseClinical Infectious Diseases · 1988 · 4 shared tags
  • Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg (A) 1986 Dec; 2631(1-2):201-51986 · 4 shared tags
  • An epidemiologic study of Lyme disease in southern SwedenNew England Journal of Medicine · 1995 · 4 shared tags
  • Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in LymphocytomaInfection and Immunity · 2007 · 4 shared tags
  • Lyme disease: recommendations for diagnosis and treatmentAnnals of Internal Medicine · 1991
  • Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitroThe Journal of Infectious Diseases · 1992